Search research articles
Contact Us
Filters
Showing results (281-290 of 481) with videos related to
Page
of 49
Sort By:
Journal of Clinical Pharmacology
|
August 28, 2015
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer
Andrew K L Goey, Tristan M Sissung, Cody J Peer, et al.
Cancer Chemotherapy and Pharmacology
|
February 14, 2013
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas
Sook Ryun Park, Giovanna Speranza, Richard Piekarz, et al.
Future Oncology (London, England)
|
April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases
Alexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Cediranib for metastatic alveolar soft part sarcoma
Shivaani Kummar, Deborah Allen, Anne Monks, et al.
American Journal of Hematology
|
November 4, 2014
Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria
Zoya Kuzmina, Verena Gounden, Lauren Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas
Lauren H Boal, John Glod, Melissa Spencer, et al.
Bone Marrow Transplantation
|
August 26, 2021
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease
Sencer Goklemez, Leorey N Saligan, Filip Pirsl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor
John Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Blood Advances
|
February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2011
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib
Ronan J Kelly, Arun Rajan, Jeremy Force, et al.
Page
of 49
Search research articles
Search
Showing results (281-290 of 481) with videos related to
Sort By:
Page
of 49
Journal of Clinical Pharmacology
|
August 28, 2015
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer
Andrew K L Goey, Tristan M Sissung, Cody J Peer, et al.
Cancer Chemotherapy and Pharmacology
|
February 14, 2013
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas
Sook Ryun Park, Giovanna Speranza, Richard Piekarz, et al.
Future Oncology (London, England)
|
April 10, 2020
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases
Alexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Cediranib for metastatic alveolar soft part sarcoma
Shivaani Kummar, Deborah Allen, Anne Monks, et al.
American Journal of Hematology
|
November 4, 2014
Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria
Zoya Kuzmina, Verena Gounden, Lauren Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas
Lauren H Boal, John Glod, Melissa Spencer, et al.
Bone Marrow Transplantation
|
August 26, 2021
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease
Sencer Goklemez, Leorey N Saligan, Filip Pirsl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor
John Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Blood Advances
|
February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2011
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib
Ronan J Kelly, Arun Rajan, Jeremy Force, et al.
Page
of 49